133 related articles for article (PubMed ID: 9139686)
1. Structural determinants for agonist binding affinity to thromboxane/prostaglandin endoperoxide (TP) receptors. Analysis of chimeric rat/human TP receptors.
Dorn GW; Davis MG; D'Angelo DD
J Biol Chem; 1997 May; 272(19):12399-405. PubMed ID: 9139686
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a rat kidney thromboxane A2 receptor: high affinity for the agonist ligand I-BOP.
D'Angelo DD; Terasawa T; Carlisle SJ; Dorn GW; Lynch KR
Prostaglandins; 1996 Oct; 52(4):303-16. PubMed ID: 8936585
[TBL] [Abstract][Full Text] [Related]
3. Platelet and vascular thromboxane A2/prostaglandin H2 receptors. Evidence for different subclasses in the rat.
Masuda A; Mais DE; Oatis JE; Halushka PV
Biochem Pharmacol; 1991 Jul; 42(3):537-44. PubMed ID: 1830482
[TBL] [Abstract][Full Text] [Related]
4. A new family of thromboxane receptor antagonists with secondary thromboxane synthase inhibition.
Pace-Asciak CR; Reynaud D; Demin P; Aslam R; Sun A
J Pharmacol Exp Ther; 2002 May; 301(2):618-24. PubMed ID: 11961065
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of the thromboxane receptor alpha, the predominant isoform expressed in human platelets.
Habib A; FitzGerald GA; Maclouf J
J Biol Chem; 1999 Jan; 274(5):2645-51. PubMed ID: 9915793
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine phosphorylation of phosphatidylinositol 3-kinase and of the thromboxane A2 (TXA2) receptor by the TXA2 mimetic I-BOP in A7r5 cells.
Morinelli TA; Finley EL; Jaffa AA; Kurtz DT; Ullian ME
Biochem Pharmacol; 1997 Jun; 53(12):1823-32. PubMed ID: 9256157
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the vascular thromboxane A2/prostaglandin endoperoxide receptor in rabbit aorta. Regulation by dexamethasone.
Sessa WC; Halushka PV; Okwu A; Nasjletti A
Circ Res; 1990 Dec; 67(6):1562-9. PubMed ID: 2147131
[TBL] [Abstract][Full Text] [Related]
8. Mutagenic analysis of platelet thromboxane receptor cysteines. Roles in ligand binding and receptor-effector coupling.
D'Angelo DD; Eubank JJ; Davis MG; Dorn GW
J Biol Chem; 1996 Mar; 271(11):6233-40. PubMed ID: 8626415
[TBL] [Abstract][Full Text] [Related]
9. Cyclic oxidation-reduction reactions regulate thromboxane A2/prostaglandin H2 receptor number and affinity in human platelet membranes.
Dorn GW
J Biol Chem; 1990 Mar; 265(8):4240-6. PubMed ID: 2137820
[TBL] [Abstract][Full Text] [Related]
10. The thromboxane receptor antagonist PBT-3, a hepoxilin stable analog, selectively antagonizes the TPalpha isoform in transfected COS-7 cells.
Qiao N; Reynaud D; Demin P; Halushka PV; Pace-Asciak CR
J Pharmacol Exp Ther; 2003 Dec; 307(3):1142-7. PubMed ID: 14560042
[TBL] [Abstract][Full Text] [Related]
11. Distinct platelet thromboxane A2/prostaglandin H2 receptor subtypes. A radioligand binding study of human platelets.
Dorn GW
J Clin Invest; 1989 Dec; 84(6):1883-91. PubMed ID: 2531760
[TBL] [Abstract][Full Text] [Related]
12. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors.
Naka M; Mais DE; Morinelli TA; Hamanaka N; Oatis JE; Halushka PV
J Pharmacol Exp Ther; 1992 Aug; 262(2):632-7. PubMed ID: 1386885
[TBL] [Abstract][Full Text] [Related]
13. Interactions of nonprostanoid trimetoquinol analogs with thromboxane A2/prostaglandin H2 receptors in human platelets, rat vascular endothelial cells and rat vascular smooth muscle cells.
Shin Y; Romstedt KJ; Miller DD; Feller DR
J Pharmacol Exp Ther; 1993 Dec; 267(3):1017-23. PubMed ID: 7903383
[TBL] [Abstract][Full Text] [Related]
14. Tissue- and species-specific differences in ligand binding to thromboxane A2 receptors.
Dorn GW
Am J Physiol; 1991 Jul; 261(1 Pt 2):R145-53. PubMed ID: 1830459
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of ligand binding to thromboxane A2/prostaglandin H2 receptors by diethylpyrocarbonate. Protection by receptor ligands and reversal by hydroxylamine.
Schrör K; Davis-Bruno K; Halushka PV
Biochem Pharmacol; 1995 Mar; 49(7):921-7. PubMed ID: 7741764
[TBL] [Abstract][Full Text] [Related]
16. Cloning and pharmacologic characterization of a thromboxane A2 receptor from K562 (human chronic myelogenous leukemia) cells.
D'Angelo DD; Davis MG; Ali S; Dorn GW
J Pharmacol Exp Ther; 1994 Nov; 271(2):1034-41. PubMed ID: 7965765
[TBL] [Abstract][Full Text] [Related]
17. Characterization of an 125I-labeled thromboxane A2/prostaglandin H2 receptor agonist.
Morinelli TA; Oatis JE; Okwu AK; Mais DE; Mayeux PR; Masuda A; Knapp DR; Halushka PV
J Pharmacol Exp Ther; 1989 Nov; 251(2):557-62. PubMed ID: 2530338
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the prostanoid TP receptor population in human nonpregnant myometrium.
Senchyna M; Crankshaw DJ
J Pharmacol Exp Ther; 1996 Oct; 279(1):262-70. PubMed ID: 8859002
[TBL] [Abstract][Full Text] [Related]
19. Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha.
Krauss AH; Woodward DF; Gibson LL; Protzman CE; Williams LS; Burk RM; Gac TS; Roof MB; Abbas F; Marshall K; Senior J
Br J Pharmacol; 1996 Mar; 117(6):1171-80. PubMed ID: 8882612
[TBL] [Abstract][Full Text] [Related]
20. Mechanism for homologous downregulation of thromboxane A2 receptors in cultured human chronic myelogenous leukemia (K562) cells.
Dorn GW
J Pharmacol Exp Ther; 1991 Oct; 259(1):228-34. PubMed ID: 1833525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
